Skip to main content
Premium Trial:

Request an Annual Quote

Becton Dickinson Acquires HandyLab

NEW YORK (GenomeWeb News) – Becton Dickinson has signed a definitive agreement to acquire molecular diagnostics firm HandyLab for an undisclosed sum.

HandyLab sells the Jaguar molecular diagnostics system, which incorporates clinical sample preparation, nucleic acid extraction, microfluidic real-time PCR amplification and detection. The Ann Arbor, Mich.-based firm launched the system in November 2008.

BD said that it plans to place its BD GeneOhm assays for methicillin-resistant Staphylococcus aureus, Clostridium difficile, and vancomycin-resistant Enterococcus on the HandyLab platform and market them as the new BD Max system.

The acquisition follows an alliance between the firms begun earlier this year aimed at placing the GeneOhm tests on the Jaguar system.

"We believe this new platform enables both our healthcare-associated infections offering and future expansion into other molecular opportunities," BD President Vincent Forlenza said in a statement.

BD said that it will provide more information on the acquisition during its fiscal fourth-quarter conference call on Nov. 4.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.